Search results :

Implanon

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: G03AC08

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5
Vaginal inflammation 14.5% x x x
Headache 1.6% - 24.9% x x x x x
Breast pain 12.8% x x x x
Upper respiratory tract infection 12.6% x
Haemorrhage 11% - 11.1% x x x
Abdominal pain 10.9% x x x x x
Pharyngitis 10.5% x x x x
Leukorrhea 9.6% x x x
Weight increased 2.3% - 13.7% x x x x x
Influenza-like symptoms 7.6% x x x
Acne 1.3% - 13.5% x x x x
Dizziness 7.2% x x x x x
Dysmenorrhoea 7.2% x x x x x
Back pain 6.8% x x x x
Nausea 6.4% x x x x x
Nervousness 5.6% x x x x x
Sinusitis 5.6% x
Hypersensitivity 5.4% x x x x
Pain postmarketing, 1% - 5.6% x x x x x
Mood swings 2.3% - 6.5% x x x x
Depression 1% - 5.5% x x x x
Haematoma 3% x x x x
Contusion postmarketing, 2% x x x x
Swelling 0.7% x x x x
Abscess postmarketing x x x x
Alopecia postmarketing x x x x x
Anaphylactic shock postmarketing x x
Angioedema postmarketing x x x x
Anxiety postmarketing x x x x
Arthralgia postmarketing x x x x
Mental disorder postmarketing x x x x
Breast disorder postmarketing x x x
Infection postmarketing x x x
Connective tissue disorder postmarketing x x x
Constipation postmarketing x x x x
Libido decreased postmarketing x x x x x
Diarrhoea postmarketing x x x x
Dysuria postmarketing x x x x
Oedema postmarketing x x x x
Rash postmarketing x x x x
Fatigue postmarketing x x x x
Body temperature increased postmarketing x x x x
Fibrosis postmarketing x x x x
Flatulence postmarketing x x x x x
Gastrointestinal disorder postmarketing x x x
Hereditary angioedema postmarketing x x x x
Hypertrichosis postmarketing x x x x
Immune system disorder postmarketing x x x
Chloasma postmarketing x x x
Musculoskeletal pain postmarketing x x x
Nervous system disorder postmarketing x x x
Ovarian cyst postmarketing x x x x
Paraesthesia postmarketing x x x x
Pregnancy postmarketing x x
Ectopic pregnancy postmarketing x x x
Pruritus postmarketing x x x x x
Pruritus genital postmarketing x x x x
Rhinitis postmarketing x x x x
Seborrhoeic dermatitis postmarketing x x x
Convulsion postmarketing x x
Urinary tract infection postmarketing x x x
Urinary tract disorder postmarketing x x x
Urticaria postmarketing x x x x
Angiopathy postmarketing x x x
Vomiting postmarketing x x x x
Weight decreased postmarketing x x x x
Breast discharge postmarketing x x x
Migraine postmarketing x x x x
Malnutrition postmarketing x x x
Unspecified disorder of skin and subcutaneous tissue postmarketing x x x
Myalgia postmarketing x x x x
Increased appetite postmarketing x x x
Blood pressure increased postmarketing x x x x
Vulvovaginal discomfort postmarketing x x x
Implant site reaction postmarketing x x x
Hot flush postmarketing x x x x
Infestation NOS postmarketing x x x
Insomnia postmarketing x x x x
Breast enlargement postmarketing x x x
Somnolence postmarketing x x x x
Anorexia x
Asthenia x
Asthma x
Breast cancer x
Cough x
Dyspepsia x
Gastritis x
Hypertension x
Hypertrophy of breast x
Liver disorder x x
Hepatic neoplasm x
Cramp muscle x
Neoplasm x
Otitis media x
Erythema x x
Varicose vein x
Generalised oedema x
Injection site reaction x x
Bone pain x
Injection site pain x
Menstruation irregular x x x
Decreased appetite x
Affect lability x
Galactorrhoea x x
Crying abnormal x
Vaginal discomfort x
Breast tenderness x
Redness x x
Depressed mood x
Premenstrual tension x
Vaginal infection x
Influenza like illness x
Surgical intervention x x
Sexual dysfunction x
Breast pain female x
Cervical smear test positive x
Genital discharge x
Fibroadenosis of breast x
Implant site pain x
Abnormal vision x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

Etonogestrel subdermal implants / Implanon NXT

Side effects:37
Source:medicines.org.au

ETONOGESTREL / NEXPLANON

Side effects:72
Source:FDA

etonogestrel

Side effects:81
Source:FDA Structured Product Label

etonogestrel

Side effects:81
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label